Clinical guidance is often sought when prescribing drugs for patients with primary mitochondrial disease. Theoretical considerations concerning drug safety in patients with mitochondrial disease may lead to unnecessary withholding of a drug in a situation of clinical need. The aim of this new study was to develop consensus on safe medication use in patients with a primary mitochondrial disease.
The study and updated Safety of Drug Use list can be viewed here.
